Anti-Interleukin-2 Receptor Antibodies for the Prevention of Rejection in Pediatric Renal Transplant Patients: Current Status

Author： Swiatecka-Urban A.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.5, Iss.10, 2003-01, pp. : 699-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Interleukin-2 Receptor Antibodies in Transplantation: What is the Basis for Choice?

By Teun van Gelder  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1737-1741

Adis International

Access to resources Recommend Favorite

Current pharmacotherapeutical options for the prevention of kidney transplant rejection

By Schaefer Sebastian M   Süsal Caner   Sommerer Claudia   Zeier Martin   Morath Christian  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1029-1041

Informa Healthcare

Access to resources Recommend Favorite

Mycophenolate Sodium Delayed Release: Prevention of Renal Transplant Rejection

By Curran Monique P.   Keating Gillian M.  

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 799-805

Adis International

Access to resources Recommend Favorite

Daclizumab: A Review of its Use in the Prevention of Acute Rejection in Renal Transplant Recipients

By Wiseman L.R.   Faulds D.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1029-1042

Adis International

Access to resources Recommend Favorite

Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 373-381

Bentham Science Publishers

Access to resources Recommend Favorite